NDUFA11

Across TCGA pan-cancer cohorts, NDUFA11 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of NDUFA11’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where NDUFA11 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types NDUFA11 is over-expressed in tumor, although a few such as CCRCC and COAD show the opposite, repressed pattern.

CCRCC, COAD, and LUAD are the cancer types where NDUFA11 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFA11 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	III,IV	−1.511	<.001	12	view →
COAD	All	All	−0.335	<.001	12	view →
LUAD	Male	All	+0.386	<.001	6	view →
LSCC	All	All	+0.303	<.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

NDUFA11–CCRCC

Open the CCRCC breakdown →